Our results in breast cancer also suggest a tumour‐promoting role of TGFBI, but they indicate that modulating TGFBI in breast cancer cells does not directly impact the CSC phenotype and therefore the metastatic potential of tumour cells. The gene discussed is TGFBI; the disease is breast carcinoma.